Kirbee Johnston

543 total citations
26 papers, 368 citations indexed

About

Kirbee Johnston is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Anesthesiology and Pain Medicine. According to data from OpenAlex, Kirbee Johnston has authored 26 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 9 papers in Economics and Econometrics and 8 papers in Anesthesiology and Pain Medicine. Recurrent topics in Kirbee Johnston's work include Opioid Use Disorder Treatment (15 papers), Pain Management and Opioid Use (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Kirbee Johnston is often cited by papers focused on Opioid Use Disorder Treatment (15 papers), Pain Management and Opioid Use (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Kirbee Johnston collaborates with scholars based in United States, Indonesia and South Korea. Kirbee Johnston's co-authors include Daniel M. Hartung, Dennis Bourdette, Adriane N. Irwin, P. Todd Korthuis, Sara E. Hallvik, David Cohen, Atul Deodhar, Gillian Leichtling, Ximena A. Levander and Kevin Novak and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Kirbee Johnston

26 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirbee Johnston United States 12 254 107 86 74 65 26 368
Aníbal García‐Sempere Spain 13 61 0.2× 71 0.7× 79 0.9× 30 0.4× 37 0.6× 43 459
L. Martínez France 12 28 0.1× 41 0.4× 33 0.4× 36 0.5× 25 0.4× 30 448
Lehana Thabane Canada 7 141 0.6× 100 0.9× 46 0.5× 19 0.3× 7 0.1× 21 324
Marie-Claude Laliberté Canada 10 42 0.2× 25 0.2× 46 0.5× 10 0.1× 139 2.1× 21 314
Charlotte Johnston-Webber United Kingdom 7 140 0.6× 28 0.3× 25 0.3× 38 0.5× 13 0.2× 13 274
Miranda Huffman United States 7 62 0.2× 38 0.4× 8 0.1× 28 0.4× 7 0.1× 13 238
Christina Slee United States 12 71 0.3× 80 0.7× 30 0.3× 43 0.6× 4 0.1× 16 376
Maja Laursen Denmark 7 84 0.3× 32 0.3× 28 0.3× 6 0.1× 10 0.2× 9 274
Carolyn McCrorie United Kingdom 5 133 0.5× 82 0.8× 33 0.4× 69 0.9× 30 0.5× 11 362
Genevieve M Hale United States 10 31 0.1× 15 0.1× 33 0.4× 18 0.2× 101 1.6× 46 294

Countries citing papers authored by Kirbee Johnston

Since Specialization
Citations

This map shows the geographic impact of Kirbee Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirbee Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirbee Johnston more than expected).

Fields of papers citing papers by Kirbee Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirbee Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirbee Johnston. The network helps show where Kirbee Johnston may publish in the future.

Co-authorship network of co-authors of Kirbee Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Kirbee Johnston. A scholar is included among the top collaborators of Kirbee Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirbee Johnston. Kirbee Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindner, Stephan, et al.. (2024). Effects Of Medicaid Waivers On Use Of Medications For Opioid Use Disorder And Nonfatal Overdoses In 17 States. Health Affairs. 43(11). 1597–1604. 3 indexed citations
2.
Hartung, Daniel M., Kirbee Johnston, Jessina C. McGregor, & Dennis Bourdette. (2022). Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population. International Journal of MS Care. 24(2). 90–97. 5 indexed citations
3.
Hartung, Daniel M., Sheila Markwardt, Kirbee Johnston, et al.. (2022). Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study. Addiction Science & Clinical Practice. 17(1). 45–45. 9 indexed citations
4.
Johnston, Kirbee, et al.. (2022). Pharmacists’ Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation. SHILAP Revista de lepidopterología. 10(5). 126–126. 1 indexed citations
5.
Irwin, Adriane N., et al.. (2021). Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden. Drug and Alcohol Dependence. 224. 108729–108729. 68 indexed citations
6.
Hartung, Daniel M., Kirbee Johnston, Jessina C. McGregor, & Dennis Bourdette. (2021). Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program. Neurology Clinical Practice. 12(1). 36–42. 2 indexed citations
7.
Hallvik, Sara E., et al.. (2021). Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin only. Journal of Substance Abuse Treatment. 132. 108615–108615. 8 indexed citations
8.
Hartung, Daniel M., Kirbee Johnston, Jessina C. McGregor, & Dennis Bourdette. (2020). The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis. Multiple Sclerosis and Related Disorders. 46. 102554–102554. 5 indexed citations
9.
Hartung, Daniel M., Kirbee Johnston, Dennis Bourdette, Randi Chen, & Chien‐Wen Tseng. (2020). Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs. Neurology Clinical Practice. 11(4). 298–303. 7 indexed citations
10.
Hartung, Daniel M., Kirbee Johnston, Sara E. Hallvik, et al.. (2020). Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study. Journal of General Internal Medicine. 35(11). 3188–3196. 12 indexed citations
11.
Novak, Kevin, et al.. (2020). Development and pilot of a prescription drug monitoring program and communication intervention for pharmacists. Research in Social and Administrative Pharmacy. 16(10). 1422–1430. 18 indexed citations
12.
Hartung, Daniel M., Kirbee Johnston, Gillian Leichtling, et al.. (2020). Patterns of Prescription Opioid Use Prior to Self-reported Heroin Initiation. Journal of Addiction Medicine. 15(2). 130–133. 4 indexed citations
13.
Hallvik, Sara E., et al.. (2020). Patient Outcomes Following Opioid Dose Reduction Among Patients with Chronic Opioid Therapy. Health Services Research. 55(S1). 105–106. 2 indexed citations
14.
Hartung, Daniel M., et al.. (2020). Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis. Neurology. 94(13). e1407–e1414. 12 indexed citations
15.
Hartung, Daniel M., Kirbee Johnston, Atul Deodhar, Dennis Bourdette, & David Cohen. (2019). Repository Corticotropin Versus Glucocorticoid for Nephrotic Syndrome: When Will We See the Evidence?. American Journal of Kidney Diseases. 74(2). 256–262. 5 indexed citations
16.
Hartung, Daniel M., Kirbee Johnston, Adriane N. Irwin, Sheila Markwardt, & Dennis Bourdette. (2019). Trends In Coverage For Disease-Modifying Therapies For Multiple Sclerosis In Medicare Part D. Health Affairs. 38(2). 303–312. 26 indexed citations
17.
Johnston, Kirbee, et al.. (2018). Pharmacists' attitudes, knowledge, utilization, and outcomes involving prescription drug monitoring programs: A brief scoping review. Journal of the American Pharmacists Association. 58(5). 568–576. 24 indexed citations
18.
Hartung, Daniel M., Kirbee Johnston, David Cohen, et al.. (2018). Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin. JAMA Network Open. 1(2). e180482–e180482. 38 indexed citations
19.
Hartung, Daniel M., et al.. (2017). Trends and Characteristics of US Medicare Spending on Repository Corticotropin. JAMA Internal Medicine. 177(11). 1680–1680. 13 indexed citations
20.
Hartung, Daniel M., Sharia M. Ahmed, Joshua Van Otterloo, et al.. (2017). Using prescription monitoring program data to characterize out‐of‐pocket payments for opioid prescriptions in a state Medicaid program. Pharmacoepidemiology and Drug Safety. 26(9). 1053–1060. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aníbal García‐Sempere Breakdown of academic impact, for papers by L. Martínez Breakdown of academic impact, for papers by Lehana Thabane Breakdown of academic impact, for papers by Marie-Claude Laliberté Breakdown of academic impact, for papers by Charlotte Johnston-Webber Breakdown of academic impact, for papers by Miranda Huffman Breakdown of academic impact, for papers by Christina Slee Breakdown of academic impact, for papers by Maja Laursen Breakdown of academic impact, for papers by Carolyn McCrorie Breakdown of academic impact, for papers by Genevieve M Hale
Rankless by CCL
2026